BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
natco pharma ltd. stock

NATCO PHARMA LTD. Share Price

1462.55 -29.44 (-1.97%)
Dec 11 2024 03:30 PM Pharmaceuticals NSE: NATCOPHARM

NATCO PHARMA LTD. Share Price Update

As of the latest trading session, NATCO PHARMA LTD. share price is currently at 1462.55, which is down by -29.44 from its previous closing. Today, the stock has fluctuated between 1460.10 and 1502.00. Over the past year, NATCO PHARMA LTD. has achieved a return of 92.33 %. In the last month alone, the return has been 6.49 %. Read More...

NATCO PHARMA LTD. Performance

Day Range

Low1460.10 High1502.00
1462.55

52 Week Range

Low 752.45 High 1639.00
1462.55

NATCO PHARMA LTD. Share Price

3918

524816

NATCOPHARM

img img img img
No Data Available

Open Price

1492.95

Prev. Close

1492.00

Volume (Shares)

446391.00

Total traded value

6528.69

Upper Circuit

1790.40

Lower Circuit

1193.60

Note: The current prices & values are delayed, Login to your account for live updates.

NATCO PHARMA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 26195.71
PE Ratio (TTM) 14.53
Book Value / Share 382.02
Beta 0.60
ROE 25.38%
EPS (TTM) 102.65
Dividend Yield 0.64%
Net Profit Qtr (Cr) 661.10

NATCO PHARMA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1292.60
Operating Expense 547.10
Net Profit 661.10
Net Profit Margin (%) 51.14
Earnings Per Share (EPS) 36.91
EBITDA 842.10
Effective Tax Rate (%) 17.04
Particulars JUN 2024 (Values in Cr)
Revenue 1236.90
Operating Expense 518.69
Net Profit 636.30
Net Profit Margin (%) 51.44
Earnings Per Share (EPS) 35.53
EBITDA 802.80
Effective Tax Rate (%) 16.05
Particulars MAR 2024 (Values in Cr)
Revenue 964.80
Operating Expense 568.20
Net Profit 349.10
Net Profit Margin (%) 36.18
Earnings Per Share (EPS) 19.49
EBITDA 488.60
Effective Tax Rate (%) 19.28
Particulars DEC 2023 (Values in Cr)
Revenue 625.30
Operating Expense 431.20
Net Profit 192.00
Net Profit Margin (%) 30.70
Earnings Per Share (EPS) 10.72
EBITDA 267.80
Effective Tax Rate (%) 14.13
Particulars SEP 2023 (Values in Cr)
Revenue 930.50
Operating Expense 531.20
Net Profit 360.20
Net Profit Margin (%) 38.71
Earnings Per Share (EPS) 20.11
EBITDA 467.00
Effective Tax Rate (%) 15.04
Particulars MAR 2024 (Values in Cr)
Revenue 3568.90
Operating Expense 2118.30
Net Profit 1306.60
Net Profit Margin (%) 36.61
Earnings Per Share (EPS) 72.79
EBITDA 1741.70
Effective Tax Rate (%) 15.99
Particulars MAR 2023 (Values in Cr)
Revenue 2351.00
Operating Expense 1665.80
Net Profit 637.10
Net Profit Margin (%) 27.09
Earnings Per Share (EPS) 34.90
EBITDA 930.20
Effective Tax Rate (%) 17.33
Particulars MAR 2022 (Values in Cr)
Revenue 1767.80
Operating Expense 1706.50
Net Profit 139.10
Net Profit Margin (%) 7.86
Earnings Per Share (EPS) 7.63
EBITDA 307.60
Effective Tax Rate (%) 10.77
Particulars MAR 2021 (Values in Cr)
Revenue 1653.50
Operating Expense 1362.39
Net Profit 309.50
Net Profit Margin (%) 18.71
Earnings Per Share (EPS) 16.99
EBITDA 518.70
Effective Tax Rate (%) 21.08
Particulars MAR 2020 (Values in Cr)
Revenue 1790.20
Operating Expense 1330.89
Net Profit 474.50
Net Profit Margin (%) 26.50
Earnings Per Share (EPS) 26.08
EBITDA 701.80
Effective Tax Rate (%) 18.62
Particulars MAR 2024 (Values in Cr)
Book Value / Share 326.99
ROE % 25.88
ROCE % 29.63
Total Debt to Total Equity 0.05
EBITDA Margin 47.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 267.06
ROE % 15.66
ROCE % 17.70
Total Debt to Total Equity 0.06
EBITDA Margin 38.42
Particulars MAR 2022 (Values in Cr)
Book Value / Share 233.62
ROE % 3.28
ROCE % 3.82
Total Debt to Total Equity 0.08
EBITDA Margin 16.44
Particulars MAR 2021 (Values in Cr)
Book Value / Share 225.84
ROE % 11.21
ROCE % 13.68
Total Debt to Total Equity 0.07
EBITDA Margin 34.59
Particulars MAR 2020 (Values in Cr)
Book Value / Share 207.34
ROE % 12.62
ROCE % 14.52
Total Debt to Total Equity 0.10
EBITDA Margin 36.03
Particulars MAR 2024 (Values in Cr)
Book Value / Share 312.42
ROE % 25.38
ROCE % 28.58
Total Debt to Total Equity 0.05
EBITDA Margin 48.80
Particulars MAR 2023 (Values in Cr)
Book Value / Share 257.64
ROE % 14.33
ROCE % 16.17
Total Debt to Total Equity 0.06
EBITDA Margin 39.57
Particulars MAR 2022 (Values in Cr)
Book Value / Share 229.69
ROE % 2.54
ROCE % 2.77
Total Debt to Total Equity 0.08
EBITDA Margin 14.98
Particulars MAR 2021 (Values in Cr)
Book Value / Share 224.17
ROE % 7.78
ROCE % 9.25
Total Debt to Total Equity 0.07
EBITDA Margin 31.37
Particulars MAR 2020 (Values in Cr)
Book Value / Share 212.61
ROE % 12.77
ROCE % 14.56
Total Debt to Total Equity 0.09
EBITDA Margin 39.20
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 952.90
Total Assets 6906.30
Total Liabilities 6906.30
Total Equity 5853.10
Share Outstanding 179109870
Price to Book Ratio 3.05
Return on Assets (%) 20.10
Return on Capital (%) 22.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 546.30
Total Assets 5657.40
Total Liabilities 5657.40
Total Equity 4873.80
Share Outstanding 182470115
Price to Book Ratio 2.19
Return on Assets (%) 12.64
Return on Capital (%) 14.2
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 206.10
Total Assets 5109.10
Total Liabilities 5109.10
Total Equity 4263.60
Share Outstanding 182337825
Price to Book Ratio 3.30
Return on Assets (%) 3.32
Return on Capital (%) 3.64
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 283.50
Total Assets 4791.90
Total Liabilities 4791.90
Total Equity 4123.40
Share Outstanding 182337825
Price to Book Ratio 3.68
Return on Assets (%) 9.20
Return on Capital (%) 10.05
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 66.00
Total Assets 4587.80
Total Liabilities 4587.80
Total Equity 3784.70
Share Outstanding 182067975
Price to Book Ratio 2.38
Return on Assets (%) 10.04
Return on Capital (%) 11.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 864.90
Total Assets 6554.00
Total Liabilities 6554.00
Total Equity 5592.30
Share Outstanding 179109870
Price to Book Ratio 3.05
Return on Assets (%) 19.93
Return on Capital (%) 21.94
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 412.00
Total Assets 5387.90
Total Liabilities 5387.90
Total Equity 4702.00
Share Outstanding 182470115
Price to Book Ratio 2.19
Return on Assets (%) 11.82
Return on Capital (%) 13.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 100.90
Total Assets 4978.00
Total Liabilities 4978.00
Total Equity 4191.90
Share Outstanding 182337825
Price to Book Ratio 3.30
Return on Assets (%) 2.79
Return on Capital (%) 3.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 262.80
Total Assets 4752.50
Total Liabilities 4752.50
Total Equity 4091.10
Share Outstanding 182337825
Price to Book Ratio 3.68
Return on Assets (%) 6.51
Return on Capital (%) 7.12
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 54.10
Total Assets 4646.70
Total Liabilities 4646.70
Total Equity 3869.50
Share Outstanding 182067975
Price to Book Ratio 2.38
Return on Assets (%) 10.21
Return on Capital (%) 11.34
Particulars MAR 2024 (Values in Cr)
Net Income 1673.50
Cash from Operations 1497.90
Cash from Investing -1032.70
Cash from Financing -246.90
Net change in Cash -68.00
Free Cash Flow 1837.30
Particulars MAR 2023 (Values in Cr)
Net Income 861.90
Cash from Operations 1026.60
Cash from Investing -477.10
Cash from Financing -363.00
Net change in Cash 9.00
Free Cash Flow 1172.89
Particulars MAR 2022 (Values in Cr)
Net Income 202.20
Cash from Operations 94.70
Cash from Investing -5.30
Cash from Financing 34.80
Net change in Cash 76.00
Free Cash Flow 327.50
Particulars MAR 2021 (Values in Cr)
Net Income 579.60
Cash from Operations 428.80
Cash from Investing -103.30
Cash from Financing -185.70
Net change in Cash 9.80
Free Cash Flow 683.40
Particulars MAR 2020 (Values in Cr)
Net Income 568.70
Cash from Operations 525.10
Cash from Investing -167.00
Cash from Financing -250.80
Net change in Cash -0.50
Free Cash Flow 880.80
Particulars MAR 2024 (Values in Cr)
Net Income 1555.30
Cash from Operations 1448.40
Cash from Investing -960.50
Cash from Financing -237.30
Net change in Cash -1.40
Free Cash Flow 1782.60
Particulars MAR 2023 (Values in Cr)
Net Income 770.70
Cash from Operations 932.80
Cash from Investing -436.60
Cash from Financing -346.80
Net change in Cash 1.00
Free Cash Flow 1075.30
Particulars MAR 2022 (Values in Cr)
Net Income 155.90
Cash from Operations 90.20
Cash from Investing -92.50
Cash from Financing 35.60
Net change in Cash 0.80
Free Cash Flow 315.70
Particulars MAR 2021 (Values in Cr)
Net Income 392.20
Cash from Operations 260.40
Cash from Investing -3.20
Cash from Financing -183.10
Net change in Cash -2.80
Free Cash Flow 500.29
Particulars MAR 2020 (Values in Cr)
Net Income 583.10
Cash from Operations 527.60
Cash from Investing -165.00
Cash from Financing -261.10
Net change in Cash -3.60
Free Cash Flow 880.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1466.90
  • 26 Days 1411.20
  • 10 Days 1434.10
  • 50 Days 1397.00
  • 12 Days 1426.70
  • 100 Days 1398.30
  • 20 Days 1415.10
  • 200 Days 1097.30
1490.80
PIVOT
First Resistance 1506.20
Second Resistance 1520.40
Third Resistance 1535.80
First Support 1476.60
Second Support 1461.20
Third Support 1447.00
RSI 68.63
MACD 15.53
Commodity Channel Index (CCI) 172.81
ADX 20.66
Williams % R -7.52

Over 1 Month

down

6.49

Over 3 Months

down

-3.90

Over 6 Months

down

35.35

Over 1 Year

down

92.33

Over 3 Years

down

19.77

Over 5 Years

down

20.68

NATCO PHARMA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

NATCO PHARMA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
26.11
Promoter Holdings
49.61
FII
17.5
DII
6.75
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
V C Nannapaneni Shareholding of Promoter and Promoter Group 2.8045905E7 15.66
Time Cap Pharma Labs Private Limited Shareholding of Promoter and Promoter Group 1.717542E7 9.59
Venkata Satya Swathi Kantamani Shareholding of Promoter and Promoter Group 1.598334E7 8.92
Natsoft Information Systems Pvt Ltd Shareholding of Promoter and Promoter Group 1.57849E7 8.81
Life Insurance Corporation Of India - P & Gs Fund Public Shareholding 5438591.0 3.04
Vistra Itcl India Limited A/c Neelima Nannapanenni Trust Shareholding of Promoter and Promoter Group 4082750.0 2.28
Durga Devi Nannapaneni Shareholding of Promoter and Promoter Group 3539100.0 1.98
Belgrave Investment Fund Public Shareholding 3445000.0 1.92
Tata Nifty 500 Multicap India Manufacturing 50:30:20 Index Fund Public Shareholding 2181685.0 1.22
Akash Bhanshali Public Shareholding 1800788.0 1.01
Rajeev Nannapaneni Shareholding of Promoter and Promoter Group 1128000.0 0.63
Ramakrishna Rao Nannapaneni Shareholding of Promoter and Promoter Group 746910.0 0.42
Vistra Itcl India Limited A/c Durgadevi Family Trust Shareholding of Promoter and Promoter Group 600000.0 0.33
T Anila Shareholding of Promoter and Promoter Group 564920.0 0.32
T Ananda Babu Shareholding of Promoter and Promoter Group 413205.0 0.23
Vidyadhari Tummala Shareholding of Promoter and Promoter Group 367200.0 0.21
Neelima Sita Nannapaneni Shareholding of Promoter and Promoter Group 182960.0 0.1
Ndl Infratech Private Limited Shareholding of Promoter and Promoter Group 93750.0 0.05
Tummala Jansi Shareholding of Promoter and Promoter Group 77100.0 0.04
Kantamani Ratna Kumar Shareholding of Promoter and Promoter Group 50000.0 0.03
Devendranth Alapati Shareholding of Promoter and Promoter Group 15000.0 0.01
Natco Aqua Limited Shareholding of Promoter and Promoter Group 16000.0 0.01
Sau Family Trust Shareholding of Promoter and Promoter Group 1700.0 0.0
Vistra Itcl India Limited A/c Vcn Family Trust Shareholding of Promoter and Promoter Group 1700.0 0.0
Bapineedu Tummala Shareholding of Promoter and Promoter Group 415.0 0.0
Bapanna Alapati Shareholding of Promoter and Promoter Group 0.0 0.0
Venkaiah Chowdary Nannapaneni Huf Shareholding of Promoter and Promoter Group 0.0 0.0

NATCO PHARMA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-26 1.25 Interim 3 2024-02-26 Equity shares 2023-11-24 1.25 Interim 2 2023-11-24 Equity shares 2023-08-22 7.0 Interim 2023-08-22 Equity shares 2023-02-21 1.25 Interim 3 2023-02-21 Equity shares 2022-11-21 0.75 Interim 2 2022-11-22 Equity shares 2022-08-19 3.5 Interim 2022-08-22 Equity shares 2022-02-24 2.0 Interim 3 2022-02-25 Equity shares 2021-11-23 0.5 Interim 2 2021-11-24 Equity shares 2021-08-24 2.0 Interim 2021-08-25 Equity shares 2021-02-22 1.0 Interim 3 2021-02-23 Equity shares 2020-11-24 3.0 Interim 2 2020-11-25 Equity shares 2020-08-21 1.25 Interim 2020-08-24 Equity shares 2020-06-26 1.0 Interim 4 2020-06-29 Equity shares 2020-02-24 3.5 Interim 3 2020-02-25 Equity shares 2019-11-21 1.0 Interim 2 2019-11-22 Equity shares 2019-08-22 1.25 Interim 2019-08-23 Equity shares 2019-06-06 1.25 Interim 3 2019-06-07 Equity shares 2019-02-21 3.5 Interim 2 2019-02-22 Equity shares 2018-08-20 1.5 Interim 2018-08-21 Equity shares 2018-02-15 7.0 Interim 2 2018-02-17 Equity shares 2017-08-16 1.25 Interim 2017-08-18 Equity shares 2017-02-23 6.0 Interim 2 2017-02-27 Equity shares 2016-08-19 0.75 Interim 2016-08-22 Equity shares 2016-02-22 1.25 Interim 2016-02-23 Equity shares 2015-02-24 5.0 Interim 2015-02-25 Equity shares 2014-02-24 5.0 Interim 2014-02-25 Equity shares 2013-02-22 4.0 Interim 2013-02-25 Equity shares 2012-02-22 3.0 Interim 2012-02-23 Equity shares 2011-02-24 2.0 Interim 2011-02-25 Equity shares 2010-02-05 2.0 Interim 2010-02-08 Equity shares 2009-06-04 1.25 Interim 2009-06-05 Equity shares 2007-11-12 1.25 Interim 2007-11-13 Equity shares 2006-11-10 0.0 Interim 0001-01-01 Equity shares 2006-11-10 1.25 Final 2006-11-13 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2015-11-26 10.0 2.0 2015-11-28

Learn More About Stocks

About NATCO PHARMA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by NATCO PHARMA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Natco Pharma Ltd?

Answer Field

The share price of Natco Pharma Ltd for NSE is ₹ 1462.55 and for BSE is ₹ 1463.45.

What is the Market Cap of Natco Pharma Ltd?

Answer Field

The market cap of Natco Pharma Ltd for NSE is ₹ 2,61,95.71 Cr. and for BSE is ₹ 2,62,11.83 Cr. as of now.

What is the 52 Week High and Low of Natco Pharma Ltd?

Answer Field

The 52 Week High and Low of Natco Pharma Ltd for NSE is ₹ 1639.00 and ₹ 752.45 and for BSE is ₹ 1638.35 and ₹ 752.55.

How to Buy Natco Pharma Ltd share?

Answer Field

You can trade in Natco Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Natco Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 93.12%.

What is the Current Share Price of Natco Pharma Ltd?

Answer Field

Natco Pharma Ltd share price is for NSE ₹ 1462.55 & for BSE ₹ 1463.45 as on Dec 11 2024 03:30 PM.

What is the Market Cap of Natco Pharma Ltd Share?

Answer Field

The market cap of Natco Pharma Ltd for NSE ₹ 2,61,95.71 & for BSE ₹ 2,62,11.83 as on Dec 11 2024 03:30 PM.

What is the P/E Ratio of Natco Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM the price-to-earnings (PE) ratio for Natco Pharma Ltd share is 14.53.

What is the PB ratio of Natco Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM, the price-to-book (PB) ratio for Natco Pharma Ltd share is 382.02.

How to Buy Natco Pharma Ltd Share?

Answer Field

You can trade in Natco Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Natco Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Natco Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Natco Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader